The report provides market dynamics and trends related to the global cancer vaccines market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from sales of cancer vaccines; however, it excludes cancer vaccines service revenue. Valuations comprise revenue generated from technologies such as dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. Furthermore, the report excludes revenue generated from post-sale services of cancer vaccines products.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CANCER VACCINES MARKET, BY TECHNOLOGY

CHAPTER 5: CANCER VACCINES MARKET, BY TYPE

CHAPTER 6: CANCER VACCINES MARKET, BY INDICATION 

CHAPTER 7: CANCER VACCINES MARKET, BY END USER

CHAPTER 8: CANCER VACCINES MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES